Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon-like Peptide-1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00688701
What this trial is testing

GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation in Monotherapy

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 361
Post-approval studies (Phase 4)Study completedNCT02049034
What this trial is testing

Lixisenatide-The Effects on Glucose and Lipid Metabolism in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
University of Surrey 8
Early research (Phase 1)Looking for participantsNCT07559500
What this trial is testing

Tirzepatide s Dopaminergic Effects in Alcohol Use Disorders (AUD)

Who this might be right for
Alcohol Use Disorder (AUD)
National Institute on Alcohol Abuse and Alcoholism (NIAAA) 176
Testing effectiveness (Phase 2)Ended earlyNCT00947011
What this trial is testing

Dipeptidyl Peptidase-4 Inhibition on Glucagon-like Peptide-1 (GLP-1)

Who this might be right for
Glucose Homeostasis
Johns Hopkins University 12
Not applicableUnknownNCT04159181
What this trial is testing

The Endocrine Colon in Humans

Who this might be right for
Healthy
University of Copenhagen 10
Testing effectiveness (Phase 2)Study completedNCT00638716
What this trial is testing

Evaluate the Efficacy and Safety of CJC-1134-PC in Patients With Type 2 Diabetes Mellitus Who Are Currently on Metformin Monotherapy

Who this might be right for
Type 2 Diabetes Mellitus
ConjuChem 122
Not applicableStudy completedNCT07677865
What this trial is testing

GLP-1 Receptor Agonists and Alzheimer's Disease: A Multi-National Target Trial Emulation

Who this might be right for
Alzheimer DiseaseDiabetes Mellitus Type 2Obesity & Overweight
West China Hospital 213,891
Large-scale testing (Phase 3)Looking for participantsNCT07193459
What this trial is testing

Study to Evaluate HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 360
Post-approval studies (Phase 4)Ended earlyNCT02767596
What this trial is testing

Evaluation of Lixisenatide Efficacy in Diabetes Mellitus Type 2 With Failure of Other GLP-1 Analog

Who this might be right for
Diabetes Mellitus Type 2
Laniado Hospital 2
Very early researchActive Not RecruitingNCT01858896
What this trial is testing

GLP-1 and Hypoglycemia

Who this might be right for
Type 2 Diabetes Mellitus
University of Maryland, Baltimore 28
Not applicableWithdrawnNCT01820273
What this trial is testing

Changes in Incretins Response and Glycemic Control After Gastric Bypass Surgery in Type 2 Diabetic Patients Versus Healthy

Who this might be right for
Type 2 DiabetesObesity
Lund University
Testing effectiveness (Phase 2)Study completedNCT02082496
What this trial is testing

GLP-1 Response and Effect in Individuals With Obesity Causing Genetic Mutations

Who this might be right for
Obesity
University of Copenhagen 50
Post-approval studies (Phase 4)UnknownNCT03648554
What this trial is testing

Researching an Effect of GLP-1 Agonist on Liver STeatosis (REALIST)

Who this might be right for
Diabetes Mellitus, Type 2NASH - Nonalcoholic Steatohepatitis
Central Hospital, Nancy, France 93
Not applicableLooking for participantsNCT07633639
What this trial is testing

GLP-1 Therapy After Bariatric Surgery in Chinese Patients With Obesity

Who this might be right for
Obesity
China-Japan Friendship Hospital 200
Not applicableUnknownNCT02507128
What this trial is testing

Effects of Glucagon Like Peptide-1 on No-reflow

Who this might be right for
Acute ST-segment Elevation Myocardial Infarction
Chen Wei Ren, MD 190
Not applicableNot Yet RecruitingNCT06927401
What this trial is testing

Evaluate the Detection of Retained Gastric Contents and Assess Safety Using the Flower Capsule Endoscopy in Healthy Individuals and GLP-1 Receptor Agonist Users

Who this might be right for
Endoscopy, Digestive SystemGLP1-R-related Disease
Asian Institute of Gastroenterology, India 36
Post-approval studies (Phase 4)Study completedNCT06027567
What this trial is testing

The Effect of an Anti-obesity Drug, Semaglutide, as Treatment in New-onset Idiopathic Intracranial Hypertension (IIH) Compared to Standard Weight Management (Dietician) With Regards to Change in Weight and Intracranial Pressure

Who this might be right for
Idiopathic Intracranial HypertensionIntracranial PressureObesity+3 more
Rigmor Højland Jensen 38
Not applicableUnknownNCT03959865
What this trial is testing

GLP-1 REceptor Agonists and Real World EvIdeNce

Who this might be right for
Type 2 Diabetes
University of Padova 6,000
Post-approval studies (Phase 4)Study completedNCT02533453
What this trial is testing

A 12/24-weeks, Open, Multi-centre, Phase IV Study on Safety and Efficacy of 2mg Exenatide Once Weekly (Bydureon) in T2DM Patients.

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 110
Testing effectiveness (Phase 2)Study completedNCT06640972
What this trial is testing

Effects of RDX-002 on Postprandial Triglycerides in Patients Discontinuing GLP-1 Agonists

Who this might be right for
TriglyceridesWeight Gain TrajectoryCholesterol, Elevated
Response Pharmaceuticals 68
Next Page